CONCERTO: A Third Phase 3 Trial for Laquinimod in MS

09:57 EDT 9 Aug 2012 | Medscape

After 2 previous trials with divergent results, Teva and Active Biotech announce that they will undertake a third trial after talks with FDA. Medscape Medical News

Original Article: CONCERTO: A Third Phase 3 Trial for Laquinimod in MS

More From BioPortfolio on "CONCERTO: A Third Phase 3 Trial for Laquinimod in MS"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

CONCERTO laquinimod, teva concerto, concerto & laquinimod, concerto laquinimod, concerto laquinimod, concerto laquinimod, laquinimode CONCERTO, laquinimod concerto, ms studie laquonimod concerto, concerto laquinimod, concerto laquinimod, laquinimod concerto clinical trials.gov, laquinimod+concerto trial, concerto laquinimod, laquinimod concerto

Latest Biotechnology, Pharmaceutical and Healthcare News

Dr. Allen’s Device Reverses Prostate Enlargement without Side Effects in Contrast to BPH Laser Surgeries and TURP, Highlights Fine Treatment

Dexia-Klagen gegen JPMorgan neu aufgerollt: Erst hin, dann her – dann wieder zurück: Der Richter, der ...

Why Do Top Athletes Suddenly Develop the Yips --a Tendency to Choke under Pressure?

Taylor Baldwin With San Diego Union Tribune Welcomes Pro Player Health Alliance And Dr. Bradley Eli On Her Show To Spread Sleep Apnea Awareness

Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients

Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy

Swallowing Magnets Can Be Fatal for Children

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.